On ECHEMI
Home > Drugs > Jiuquan Dadeli Pharmaceutical Co., Ltd.
Jiuquan Dadeli Pharmaceutical Co., Ltd.
  • Founded in:

    2003-04-21
  • Country:

    China China
  • Address:

    No. 6, Dadeli Road, High-tech Industrial Park, Suzhou District, Jiuquan City, Gansu Province
  • Tax NO.:

    9162090074589132XP
  • Registered Funds:

    59.43 million yuan
  • Website:

  • Email:

Related Drugs
Thymopentin
Name Description Content CAS NO. Registered Holders
Thymopentin

Extract from the above information

More

Extract from the above information

69558-55-0 41
Metronidazole and glucose injection
This product is a compound preparation, its components are: metronidazole 0.2%, glucose 5%.
Name Description Content CAS NO. Registered Holders
Metronidazole

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. When the concentration is 1-2 mg/L, the histolytica amoeba can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica amoeba can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. Metronidazole is carcinogenic to some animals.

More

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. When the concentration is 1-2 mg/L, the histolytica amoeba can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica amoeba can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. Metronidazole is carcinogenic to some animals.

0.2% 443-48-1 39
GLUCOSE

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. Metronidazole is carcinogenic to some animals.

More

This product is a nitroimidazole derivative that can inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. Metronidazole has a killing effect on anaerobic microorganisms, and the metabolites generated when it is reduced in the human body also have anti-anaerobic effects, inhibiting the synthesis of bacterial deoxyribonucleic acid, thereby interfering with the growth and reproduction of bacteria, and ultimately causing bacterial death. Metronidazole is carcinogenic to some animals.

5% 58367-01-4 15
Adenosylcobalamin for injection
The main ingredient of this product is adenosine diamine
Name Description Content CAS NO. Registered Holders
Adenosine

This product is a congener of cyanocobalamin B12. It is an important coenzyme for the synthesis of nucleotides in cells, participates in methyl conversion and folic acid metabolism in the body, and promotes the reduction of methylfolate to tetrahydrofolate; it also participates in the tricarboxylic acid cycle, which is very important for the formation of lipoproteins in nerve myelin, and can keep sulfhydryl enzymes in an active state, thereby participating in a wide range of protein and fat metabolism. This product can promote the development and maturation of red blood cells, which is a necessary factor for the complete formation of nerve sheath spinal cord fibers and maintaining the function of epithelial cells in the digestive system.

More

This product is a congener of cyanocobalamin B12. It is an important coenzyme for the synthesis of nucleotides in cells, participates in methyl conversion and folic acid metabolism in the body, and promotes the reduction of methylfolate to tetrahydrofolate; it also participates in the tricarboxylic acid cycle, which is very important for the formation of lipoproteins in nerve myelin, and can keep sulfhydryl enzymes in an active state, thereby participating in a wide range of protein and fat metabolism. This product can promote the development and maturation of red blood cells, which is a necessary factor for the complete formation of nerve sheath spinal cord fibers and maintaining the function of epithelial cells in the digestive system.

0
Ligustrazine Hydrochloride Injection
The main ingredient of this product is ligustrazine hydrochloride.
Name Description Content CAS NO. Registered Holders
Ligustrazine Hydrochloride

It has the effects of anti-platelet aggregation, dilating arterioles, improving microcirculation, activating blood circulation and removing blood stasis, and has the effect of disaggregating aggregated platelets

More

It has the effects of anti-platelet aggregation, dilating arterioles, improving microcirculation, activating blood circulation and removing blood stasis, and has the effect of disaggregating aggregated platelets

76494-51-4 12
Benoate
Name Description Content CAS NO. Registered Holders
BENORILATE

Not explicitly mentioned

More

Not explicitly mentioned

5003-48-5 12
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.